MedPath

The IndONEsia ICCU Registry: a Multicenter Cohort of Intensive Cardiovascular Care Units Patients in Indonesia

Completed
Conditions
Infections
Chronic Kidney Diseases
Cardiovascular Diseases
Acute Coronary Syndrome
Heart Disease, Coronary
Stroke
Shock
Heart Failure
Sepsis
Registration Number
NCT06265714
Lead Sponsor
Indonesia University
Brief Summary

Patients in the Intensive Cardiovascular Care Unit (ICCU) often present with cardiovascular disease (CVD) issues accompanied by various non-cardiovascular conditions. However, a widely applicable scoring system to predict patient outcomes in the ICCU is lacking. Therefore, developing and validating scores for predicting ICCU patient outcomes are warranted. The aims of the IndONEsia ICCU (One ICCU) registry include developing an epidemiological registry of ICCU patients and establishing a multicentre research network to analyse patient outcomes.This nationwide multicenter cohort will capture data from patients receiving cardiovascular critical care treatment in 10 Indonesian hospitals with ICCU facilities. Recorded data will encompass demographic characteristics, physical examination findings at hospital and ICCU admission, diagnoses at ICCU admission, therapy, intervention, complications on days 3 and 5 of in-ICCU care, in-hospital outcomes, and 30-day outcomes. The One ICCU is a large, prospective registry describing the care process and advancing clinical knowledge in ICCU patients. It will serve as an investigational platform for predicting the mortality of ICCU patients.

Detailed Description

This prospective cohort registry study protocol comprised all consecutive primary medical ICCU admissions across one speciality hospital and nine general hospitals in Indonesia. The participating hospitals include the specialized National Cardiovascular Center Harapan Kita in Jakarta and nine general hospitals: Dr. Sardjito General Hospital in Yogyakarta, Dr. Wahidin Sudirohusodo General Hospital in Makassar, H. Adam Malik General Hospital in Medan, Dr. Saiful Anwar General Hospital in Malang, Dr. M. Djamil General Hospital in Padang, Dr. Iskak General Hospital in Tulungagung, Prof. Ngoerah General Hospital in Denpasar, Prof. Dr. R. D. Kandou General Hospital Manado, and Dr. Kariadi General Hospital Semarang. Each participating hospital will contribute data for all consecutive medical ICCU admissions for a period of 2 years, from 2021 to 2023. The participating hospitals were carefully selected to represent all regions of Indonesia.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12950
Inclusion Criteria
  • Patients admitted to the ICCU
  • Aged 18 years or older
  • Provide consent to participate in the study
Exclusion Criteria
  • Postoperative management following cardiac surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alive1 to 30 days

Patient alive after being treated in ICCU.

Rehospitalization1 to 30 days

Readmission to the hospital within 30 days of discharge after treatment.

Readmitted to ICCU1 to 30 days

If a patient is readmitted to the ICCU after being transferred to a regular ward.

Death1 to 30 days

Patient death after being treated in ICCU.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (9)

Prof. dr. I.G.N.G. Ngoerah General Hospital

🇮🇩

Denpasar, Bali, Indonesia

Sardjito General Hospital

🇮🇩

Yogyakarta, Indonesia

Dr. M. Djamil Padang General Hospital

🇮🇩

Padang, West Sumatra, Indonesia

National Cardiovacular Center Harapan Kita

🇮🇩

Jakarta, Indonesia

Dr. Iskak General Hospital

🇮🇩

Tulung Agung, East Java, Indonesia

Dr. Kariadi General Hospital

🇮🇩

Semarang, Central Java, Indonesia

Dr. Saiful Anwar General Hospital

🇮🇩

Malang, East Java, Indonesia

Dr. Wahidin Sudirohusodo General Hospital

🇮🇩

Makassar, South Sulawesi, Indonesia

Prof. Dr. R. D. Kandou Manado General Hospital

🇮🇩

Manado, North Sulawesi, Indonesia

© Copyright 2025. All Rights Reserved by MedPath